Establishment Labs Holdings Inc. is a global medical device company that designs, develops, manufactures, and markets innovative breast augmentation and reconstruction products, tools, and techniques. The Company primarily provides clinically and commercially differentiated Motiva breast implants, which demonstrate improved biocompatibility from nanosurface technology and offer enhanced ergonomic design with proprietary silicone formulations. The Company recently launched Flora, a novel tissue expander that includes a magnet-free RFID port, which provides top-line breast reconstruction outcomes to women following breast cancer. The Company is also in the process of launching Motiva Mia, a minimally-invasive breast augmentation procedure that significantly reduces operation and recovery times and has the potential to expand the total addressable market. The Company currently sells its products in Europe, Latin America, and the Asia-Pacific via exclusive distributors and direct sales, and it plans to expand into the United States and China in the near term.